Skip to Main Content

Advertisement

Skip Nav Destination

Retraction: Abstract 408: ACP-196, An Orally Bioavailable Covalent Selective Inhibitor of Btk, Modulates the Innate Tumor Microenvironment, Exhibits Antitumor Efficacy and Enhances Gemcitabine Activity in Pancreatic Cancer

Cancer Res (2017) 77 (17): 4737.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal